ALLIANCE A031902

Primary Category:

Treatment Protocols

Disease Category:

Genitourinary, Prostate Metastatic

Status:

Open

CASPAR – A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer

Eligible for screening study DCP 001

A031902 is reactivated to new patient enrollment, effective  July 27, 2021.

NCT#04455750